Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07535541
Recruiting
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Not applicable · United States · 1 site
Registry update: 9 Jun 2026
NCT07594314
Recruiting
Minocycline After Successful Endovascular Thrombectomy Recanalization in Acute Anterior Circulation Large Vessel Occlusion (ATTRACTION-MINOA)
Phase 2/3 · China · 1 site
Registry update: 27 May 2026
NCT07616999
Recruiting
A 20-Year Follow-up of First Episode Psychosis: Longitudinal Effects of Early Treatment Strategies and Relapse
Not applicable · China · 1 site
Registry update: 26 Jun 2026
NCT07393282
Recruiting
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
Phase 3 · Germany, Spain, France, United Kingdom, Greece, Italy, Japan, South Korea, Norway, Poland, United States · 75 sites
Registry update: 4 Nov 2026
NCT07578571
Recruiting
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
Phase 1 · United States · 5 sites
Registry update: 3 Nov 2026
NCT07675551
Recruiting
Peel Family Diabetes Prevention Program
Not applicable · Canada · 2 sites
Registry update: 2 Oct 2026
NCT07551167
Recruiting
A Clinical Study of HRS-5765 in Healthy Participants
Phase 1 · China · 1 site
Registry update: 26 May 2026
NCT07431099
Recruiting
Skin Color Matching in Head and Neck Reconstructive Surgery
Not applicable · United States · 3 sites
Registry update: 29 May 2026
NCT07572032
Recruiting
Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Phase 4 · South Korea · 4 sites
Registry update: 2 Sept 2026
NCT07625540
Recruiting
Subthalamic Nucleus-Targeted Transcranial Temporal Interference Stimulation for Motor and Non-Motor Symptoms in Parkinson's Disease
Not applicable · China · 1 site
Registry update: 4 Jun 2026
NCT07483359
Recruiting
Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus
Phase 2 · China · 1 site
Registry update: 28 May 2026
NCT07799935
Recruiting
IRE After Chemotherapy for Locally Advanced Pancreatic Cancer
Not applicable · China · 1 site
Registry update: 2 Sept 2026
NCT07768644
Recruiting
Nailfold Capillaroscopy in PH
Not applicable · United Kingdom · 1 site
Registry update: 17 Aug 2026
NCT07549399
Recruiting
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC
Phase 3 · China · 1 site
Registry update: 1 Jul 2026
NCT07627815
Recruiting
Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Phase 2 · Canada · 4 sites
Registry update: 4 Jun 2026
NCT07646639
Recruiting
Different-Dose SCRT Plus CAPOX, PD-1 Blockade and IL-2 in LARC
Phase 2 · China · 1 site
Registry update: 15 Jun 2026
NCT06274879
Recruiting
Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer
Phase 2 · Switzerland · 4 sites
Registry update: 26 May 2026
NCT06317818
Recruiting
Is local injection of mesenchymal stem cells after endoscopic dilation safe and does it improve the outcome of intestinal stricture in patients with Crohn's disease?
Phase 2 · Belgium · 1 site
Registry update: 19 May 2026
NCT07190404
Recruiting
Multicontext Approach for Cognitive Function in Parkinson Disease
Not applicable · United States · 1 site
Registry update: 14 Jul 2026
NCT07242547
Recruiting
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
Phase 2 · Spain · 20 sites
Registry update: 8 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.